Dr. Jennell Vick's clinical trials using Opti-Speech at the Cleveland Hearing and Speech Center were featured in a news story on Cleveland's local station WKYC. The Opti-Speech clinical trials are supported by a Phase II SBIR grant from the NIDCD. If you live in or near Cleveland, OH or Dallas, TX and are interested in participating, you can contact Rebecca Mental at CHSC (for OH participants) or Holle Carey at Vulintus (for TX participants).